Molecular chaperones in Parkinson's disease--present and future - Wikidata - awgldk - TriplyDB

Molecular chaperones in Parkinson's disease--present and future

Molecular chaperones in Parkinson's disease--present and future

http://www.wikidata.org/entity/Q35688796

about

Molecular chaperones and co-chaperones in Parkinson disease Protein degradation pathways in Parkinson's disease: curse or blessing Molecular chaperones and protein folding as therapeutic targets in Parkinson's disease and other synucleinopathies Identification of chaperones in a MPP+-induced and ATRA/TPA-differentiated SH-SY5Y cell PD model.Protein Quality Control by Molecular Chaperones in Neurodegeneration.A toxic imbalance of Hsp70s in Saccharomyces cerevisiae is caused by competition for cofactors.Heat shock protein 90 is a potential therapeutic target for ameliorating skeletal muscle abnormalities in Parkinson's disease Formation of neurodegenerative aggresome and death-inducing signaling complex in maternal diabetes-induced neural tube defects.Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments.Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases.Factor inhibiting HIF1-A novel target of SUMOylation in the human placenta.The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates.HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neurons Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches

P2860

Q26828834-96E2581C-A6BE-448B-B17A-A80357D40B0F Q27026029-AB41F084-789B-492D-A283-EAFD59DEB6C7 Q33715640-8EF44C20-8C4D-4087-968A-725FB4997AC1 Q37553863-DDC87D06-CACF-4A27-9740-D5AC0CB408E7 Q37739093-53DA30AA-CB2A-47DD-83FF-9863352C8F96 Q38664570-67E8175A-5ACA-414B-82E9-9AFE8F393561 Q42845134-0AD55E8B-F9EE-4FDF-87C6-A2543009EF71 Q43100860-3116D370-E802-4495-AAC7-FD48037B2D32 Q45873810-238121F9-03F9-4354-ABEB-28D73EDE899C Q47335457-E432CBC9-D676-4E6B-9464-5A2C30E2381D Q49211105-071F1175-C2C4-464F-8BFF-BEF3E19D1E82 Q52584217-270166E0-438F-48F1-B2C0-F96E961442B3 Q57810923-6EF73B98-8DF1-44D5-B448-E4EF2E361E61 Q58737028-27A37E60-6C5E-4704-8CCB-AA85155A3CB6

P2860

Molecular chaperones in Parkinson's disease--present and future

http://www.wikidata.org/entity/Q35688796

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Molecular chaperones in Parkinson's disease--present and future

@ast

Molecular chaperones in Parkinson's disease--present and future

@en

type

label

Molecular chaperones in Parkinson's disease--present and future

@ast

Molecular chaperones in Parkinson's disease--present and future

@en

prefLabel

Molecular chaperones in Parkinson's disease--present and future

@ast

Molecular chaperones in Parkinson's disease--present and future

@en

P1433

Q35688796-345D767D-452F-4378-B420-9B1FF8A123F6

P1476

Q35688796-BAFFB9B2-6FD2-4E2F-A2F9-EFEC6B5D251E

P2093

Q35688796-2AAC6CDD-B5BF-4023-A558-60A3809950E9

Q35688796-B5874D8C-A94E-47F2-B65D-3B9DB0C7AACD

Q35688796-DD7B3E5B-76C2-4903-B993-2849C34C88E2

P2860

Q35688796-001F828F-9CBB-44A0-A28B-EFD1925F7918

Q35688796-004AE315-5963-4D97-BC7F-3C159D6EB57E

Q35688796-03ADBD3F-4030-41ED-BF39-3030D7319B11

Q35688796-04D9D53E-46D6-42FD-8F47-0D539F399FBF

Q35688796-04DD0355-5263-4112-84CE-CE3183EAABEE

Q35688796-05A49894-E110-4B2A-9C01-4A948A8F20F7

Q35688796-061FF91E-E7D9-490D-905A-5F20242B9599

Q35688796-068D6309-80C4-462E-B1CF-C13C8C999B9A

Q35688796-070A3304-7C0D-4400-8EFC-95CF6954009C

Q35688796-07B0FD8B-6442-4786-A264-BB537F9886B8

P304

Q35688796-2F2F8E12-4378-41CE-8483-6A1D79F4B28B

P31

Q35688796-56602AC7-FF62-456E-8AB1-B69ADACFA3C1

P433

Q35688796-E044988E-CBB5-48F5-B2EA-8465AB9C6DEF

P478

Q35688796-90E5D075-9C59-4611-9885-3455E3D26A7B

P577

Q35688796-51135E89-468A-4B31-8429-9AF8E07BFDF7

P698

Q35688796-B7E858E8-D849-42A7-8DAB-475C5C192DA9

P921

Q35688796-D7B9ECE2-8D65-427B-97C7-B88C0498AF99

P932

Q35688796-1E7392C2-E8AC-421C-BB19-E8E4415123B7

P1433

Journal of Parkinson's disease

P1476

Molecular chaperones in Parkinson's disease--present and future

@en

P2093

Darius Ebrahimi-Fakhari

http://www.w3.org/2001/XMLSchema#string

Lara Wahlster

http://www.w3.org/2001/XMLSchema#string

Pamela J McLean

http://www.w3.org/2001/XMLSchema#string

P2860

Gene therapy in Parkinson's disease: rationale and current status

The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins

Molecular markers of early Parkinson's disease based on gene expression in blood

The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity

Identification of potential protein interactors of Lrrk2

CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity

Chaperone proteostasis in Parkinson's disease: stabilization of the Hsp70/alpha-synuclein complex by Hip

BAG-1 modulates the chaperone activity of Hsp70/Hsc70.

Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models

BAG5 inhibits parkin and enhances dopaminergic neuron degeneration

P304

299-320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22279517

http://www.w3.org/2001/XMLSchema#string

P921

molecular chaperones

P932

3264060

http://www.w3.org/2001/XMLSchema#string